PULSE BIOSCIENCES, INC. (PLSE) › Cash & EquivalentsPULSE BIOSCIENCES, INC. (PLSE) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2014: $7.01M2015: $3.61M2016: $2.09M2017: $3.39M2018: $51.10M2019: $6.90M2020: $12.46M2021: $28.61M2022: $61.14M2023: $44.37M2024: $118.04M2025: $80.73M$80.73M2014Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$80.73M-31.6%2024$118.04M+166.1%2023$44.37M-27.4%2022$61.14M+113.7%2021$28.61M+129.6%2020$12.46M+80.6%2019$6.90M-86.5%2018$51.10M+1409.2%2017$3.39M+62.1%2016$2.09M-42.1%2015$3.61M-48.6%2014$7.01M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share